These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7824274)

  • 1. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
    Curtis DJ; Robb L; Strasser A; Begley CG
    Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
    Robb L; Begley CG
    Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line.
    Elwood NJ; Cook WD; Metcalf D; Begley CG
    Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
    Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
    EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
    Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
    Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
    Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
    Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCL and related hemopoietic helix-loop-helix transcription factors.
    Green AR; Begley CG
    Int J Cell Cloning; 1992 Sep; 10(5):269-76. PubMed ID: 1453013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia.
    Elwood NJ; Begley CG
    Cell Growth Differ; 1995 Jan; 6(1):19-25. PubMed ID: 7718483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
    Baer R
    Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
    van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
    Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.
    Murrell AM; Green AR
    Oncogene; 1995 Feb; 10(4):631-9. PubMed ID: 7862440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SCL transcription factor and differential regulation of macrophage differentiation by LIF, OSM and IL-6.
    Begley CG
    Stem Cells; 1994; 12 Suppl 1():143-9; discussion 149-51. PubMed ID: 7696958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc.
    Vaillant F; Blyth K; Terry A; Bell M; Cameron ER; Neil J; Stewart M
    Oncogene; 1999 Nov; 18(50):7124-34. PubMed ID: 10597314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
    Shivdasani RA; Mayer EL; Orkin SH
    Nature; 1995 Feb; 373(6513):432-4. PubMed ID: 7830794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
    Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
    Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukaemia -- a developmental perspective.
    Izraeli S
    Br J Haematol; 2004 Jul; 126(1):3-10. PubMed ID: 15198727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
    Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
    Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythroid expression of the 'helix-loop-helix' gene, SCL.
    Green AR; Salvaris E; Begley CG
    Oncogene; 1991 Mar; 6(3):475-9. PubMed ID: 2011404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1.
    Zeuner A; Eramo A; Testa U; Felli N; Pelosi E; Mariani G; Srinivasula SM; Alnemri ES; Condorelli G; Peschle C; De Maria R
    Cell Death Differ; 2003 Aug; 10(8):905-13. PubMed ID: 12867998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.